| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 73.327 | 109.285 | 117.367 | 158.234 | 201.816 | 218.151 |
| Total Income - EUR | - | - | - | 0 | 76.665 | 115.326 | 125.101 | 165.143 | 212.186 | 225.451 |
| Total Expenses - EUR | - | - | - | 4.944 | 68.725 | 97.245 | 108.200 | 146.646 | 189.650 | 202.875 |
| Gross Profit/Loss - EUR | - | - | - | -4.944 | 7.940 | 18.081 | 16.901 | 18.498 | 22.536 | 22.576 |
| Net Profit/Loss - EUR | - | - | - | -4.944 | 7.207 | 16.987 | 15.727 | 16.902 | 20.512 | 19.986 |
| Employees | - | - | - | 1 | 2 | 2 | 3 | 3 | 4 | 4 |
Check the financial reports for the company - Helpmed Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.306 | 1.120 | 942 | 768 | 616 | 461 | 305 |
| Current Assets | - | - | - | 3.624 | 22.081 | 31.120 | 44.308 | 63.920 | 86.930 | 91.039 |
| Inventories | - | - | - | 2.500 | 12.013 | 17.019 | 25.632 | 34.983 | 41.778 | 55.475 |
| Receivables | - | - | - | 876 | 8.759 | 10.848 | 12.096 | 19.638 | 20.322 | 16.406 |
| Cash | - | - | - | 247 | 1.309 | 3.254 | 6.580 | 9.299 | 24.829 | 19.157 |
| Shareholders Funds | - | - | - | -4.901 | 2.401 | 19.342 | 29.107 | 39.696 | 51.957 | 40.566 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 9.830 | 20.801 | 12.721 | 15.969 | 24.840 | 35.433 | 50.778 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Helpmed Pharma S.r.l.